These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1859 related items for PubMed ID: 23305964

  • 1. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
    Serebryanskaya TV, Yung T, Bogdanov AA, Shchebet A, Johnsen SA, Lyakhov AS, Ivashkevich LS, Ibrahimava ZA, Garbuzenco TS, Kolesnikova TS, Melnova NI, Gaponik PN, Ivashkevich OA.
    J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[d]thiazol-2-amine as the primary ligand.
    Gao E, Liu L, Zhu M, Huang Y, Guan F, Gao X, Zhang M, Wang L, Zhang W, Sun Y.
    Inorg Chem; 2011 Jun 06; 50(11):4732-41. PubMed ID: 21520903
    [Abstract] [Full Text] [Related]

  • 3. Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.
    Ruiz J, Villa MD, Cutillas N, López G, de Haro C, Bautista D, Moreno V, Valencia L.
    Inorg Chem; 2008 Jun 02; 47(11):4490-505. PubMed ID: 18447329
    [Abstract] [Full Text] [Related]

  • 4. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S, Kalayda GV, Lutz M, Spek AL, Yamanaka Y, Sato T, Chikuma M, Reedijk J.
    J Med Chem; 2003 Mar 27; 46(7):1210-9. PubMed ID: 12646031
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
    Liu W, Chen X, Xie M, Lou L, Ye Q, Yu Y, Hou S.
    J Inorg Biochem; 2008 Oct 27; 102(10):1942-6. PubMed ID: 18707762
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Platinum(II) compounds with chelating ligands based on pyridine and pyrimidine: synthesis, characterizations, DFT calculations, cytotoxic assays and binding to a DNA model base.
    Roy S, Westmaas JA, Buda F, Reedijk J.
    J Inorg Biochem; 2009 Sep 27; 103(9):1278-87. PubMed ID: 19656572
    [Abstract] [Full Text] [Related]

  • 9. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C, Bettio F, Baccichetti F, Trevisan A, Giovagnini L, Fregona D.
    Chem Biol Interact; 2004 Jun 30; 148(1-2):37-48. PubMed ID: 15223355
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S, Takayama H, Suzuki T, Odani A, Yamori T, Chikuma M.
    Metallomics; 2013 May 30; 5(5):461-8. PubMed ID: 23608770
    [Abstract] [Full Text] [Related]

  • 12. Acetonimine and 4-imino-2-methylpentan-2-amino platinum(II) complexes: synthesis and in vitro antitumor activity.
    Ruiz J, Rodríguez V, Cutillas N, López G, Bautista D.
    Inorg Chem; 2008 Nov 03; 47(21):10025-36. PubMed ID: 18844342
    [Abstract] [Full Text] [Related]

  • 13. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
    Sbovata SM, Bettio F, Mozzon M, Bertani R, Venzo A, Benetollo F, Michelin RA, Gandin V, Marzano C.
    J Med Chem; 2007 Sep 20; 50(19):4775-84. PubMed ID: 17713897
    [Abstract] [Full Text] [Related]

  • 14. Platinum complexes with 5-methyl-5(4-pyridyl)hydantoin and its 3-methyl derivatives: synthesis and cytotoxic activity - quantitative structure-activity relationships.
    Bakalova A, Varbanov H, Buyukliev R, Momekov G, Ivanov D, Doytchinova I.
    Arch Pharm (Weinheim); 2011 Apr 20; 344(4):209-16. PubMed ID: 21469169
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.
    Kratochwil NA, Zabel M, Range KJ, Bednarski PJ.
    J Med Chem; 1996 Jun 21; 39(13):2499-507. PubMed ID: 8691447
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Structure and dynamics of methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside complexes with PtCl(2) and PdCl(2), by (1)H, (2)H, (13)C, (15)N and (195)Pt NMR spectroscopy in DMSO, CD(3)CN and H(2)O.
    Bednarek E, Sitkowski J, Kawecki R, Kozerski L, Bocian W, Pazderski L, Priebe W.
    Dalton Trans; 2008 Aug 21; (31):4129-37. PubMed ID: 18688431
    [Abstract] [Full Text] [Related]

  • 18. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
    Roy S, Maheswari PU, Lutz M, Spek AL, den Dulk H, Barends S, van Wezel GP, Hartl F, Reedijk J.
    Dalton Trans; 2009 Dec 28; (48):10846-60. PubMed ID: 20023915
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
    Muscella A, Calabriso N, De Pascali SA, Urso L, Ciccarese A, Fanizzi FP, Migoni D, Marsigliante S.
    Biochem Pharmacol; 2007 Jun 30; 74(1):28-40. PubMed ID: 17481588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 93.